Blood platelet function abnormalities in cirrhotic patients with esophageal varices in relation to the variceal bleeding history*

References

• de Franchis R, Faculty BV. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762–768.
   PubMed Web of Science ®Google Scholar
• Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981;80:800–809.
   PubMed Web of Science ®Google Scholar
• Stravitz RT. Potential applications of thromboelastography in patients with acute and chronic liver disease. Gastroenterol Hepatol (N Y). 2012;8:513–520.
   PubMedGoogle Scholar
• Garcia-Tsao G, Sanyal AJ, Grace ND, Diseases PGCotAAftSoL, Gastroenterology PPCotACo, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922–938.
   PubMed Web of Science ®Google Scholar
• Kamath PS, Kim WR, Group ALDS. The model for end-stage liver disease (MELD). Hepatology. 2007;45:797–805.
   PubMed Web of Science ®Google Scholar
• Aabakken L, Rembacken B, LeMoine O, et al. Minimal standard terminology for gastrointestinal endoscopy - MST 3.0. Endoscopy. 2009;41:727–728.
   PubMed Web of Science ®Google Scholar
• Irani S, Kowdley K, Kozarek R. Gastric varices: an updated review of management. J Clin Gastroenterol. 2011;45:133–148.
   PubMed Web of Science ®Google Scholar
• Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschr. 1948;26:577–583.
   PubMed Web of Science ®Google Scholar
• Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol. 2005;27:81–90.
   PubMedGoogle Scholar
• Schramko A, Suojaranta-Ylinen R, Niemi T, et al. The use of balanced HES 130/0.42 during complex cardiac surgery; effect on blood coagulation and fluid balance: a randomized controlled trial. Perfusion. 2015;30:224–232.
   PubMed Web of Science ®Google Scholar
• Rubak P, Villadsen K, Hvas AM. Reference intervals for platelet aggregation assessed by multiple electrode platelet aggregometry. Thromb Res. 2012;130:420–423.
   PubMed Web of Science ®Google Scholar
• Skipper MT, Rubak P, Stentoft J, et al. Evaluation of platelet function in thrombocytopenia. Platelets. 2018;29:270–276.
   PubMed Web of Science ®Google Scholar
• Sukhu K, Martin PG, Cross L, et al. Evaluation of the von Willebrand factor antigen (vWF-Ag) assay using an immuno-turbidimetric method (STA Liatest vWF) automated on the MDA 180 coagulometer. Clin Lab Haematol. 2000;22:29–32.
   PubMedGoogle Scholar
• Holmberg L, Berntorp E, Donnér M, et al. von Willebrand's disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma. Blood. 1986;68:668–672.
   PubMed Web of Science ®Google Scholar
• Hugenholtz GG, Porte RJ, Lisman T. The platelet and platelet function testing in liver disease. Clin Liver Dis. 2009;13:11–20.
   PubMed Web of Science ®Google Scholar
• Ferroni P, Mammarella A, Martini F, et al. Increased soluble P-selectin levels in hepatitis C virus-related chronic hepatitis: correlation with viral load. J Investig Med. 2001;49:407–412.
   PubMed Web of Science ®Google Scholar
• Pihusch R, Rank A, Göhring P, et al. Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease. J Hepatol. 2002;37:548–555.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Shiraishi K, Itakura M, et al. Relationship between platelet membrane lipid compositions and platelet aggregability in alcoholic liver disease. Alcohol Clin Exp Res. 1998;22:97S–102S.
   PubMed Web of Science ®Google Scholar
• Davì G, Migneco G, Vigneri S, et al. Platelet thromboxane production in liver cirrhosis. Prostaglandins Leukot Med. 1985;19:99–104.
   PubMedGoogle Scholar
• Hillbom M, Neiman J. Platelet thromboxane formation capacity after ethanol withdrawal in chronic alcoholics. Pathophysiol Haemos Thromb. 1988;18:170–178.
   Google Scholar
• Torres Duarte AP, Dong QS, Young J, et al. Inhibition of platelet aggregation in whole blood by alcohol. Thromb Res. 1995;78:107–115.
   PubMed Web of Science ®Google Scholar
• Rubin R. Effects of ethanol on platelets. Lab Invest. 1990;63:729–732.
   PubMed Web of Science ®Google Scholar
• Moiny G, Thirion A, Deby C. Bilirubin induces platelet aggregation. Thromb Res. 1990;59:413–416.
   PubMed Web of Science ®Google Scholar
• Kundur AR, Bulmer AC, Singh I. Unconjugated bilirubin inhibits collagen induced platelet activation. Platelets. 2014;25:45–50.
   PubMed Web of Science ®Google Scholar
• Kundur AR, Singh I, Bulmer AC. Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert's syndrome? Atherosclerosis. 2015;239:73–84.
   PubMed Web of Science ®Google Scholar
• Baele G, Rasquin K, Barbier F. Coagulant, fibrinolytic, and aggregating activity in ascitic fluid. Am J Gastroenterol. 1986;81:440–443.
   PubMed Web of Science ®Google Scholar
• Raparelli V, Basili S, Carnevale R, et al. Low-grade endotoxemia and platelet activation in cirrhosis. Hepatology. 2017;65:571–581.
   PubMed Web of Science ®Google Scholar
• Meißner A, Schlenke P. Massive bleeding and massive transfusion. Transfus Med Hemother. 2012;39:73–84.
   PubMed Web of Science ®Google Scholar
• Caldwell S, Lisman T. The cirrhotic platelet: shedding light on an enigma. Hepatology. 2017;65:407–410.
   PubMed Web of Science ®Google Scholar
• Alkozai EM, Porte RJ, Adelmeijer J, et al. No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma. Thromb Res. 2015;135:292–297.
   PubMed Web of Science ®Google Scholar
• Schött U, Johansson PI. II. Bringing flow into haemostasis diagnostics. Br J Anaesth. 2013;111:864–867.
   PubMed Web of Science ®Google Scholar
• Ogawa S, Ohnishi T, Hosokawa K, et al. Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions. Br J Anaesth. 2013;111:1013–1023.
   PubMed Web of Science ®Google Scholar
• Ågren A, Holmström M, Schmidt DE, et al. Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system. Thromb Haemost. 2017;117:75–85.
   PubMed Web of Science ®Google Scholar
• Johansson PI, Stensballe J, Rasmussen LS, et al. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011;254:194–200.
   PubMed Web of Science ®Google Scholar
• Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008;359:938–949.
   PubMed Web of Science ®Google Scholar
• Conn HO. A peek at the Child-Turcotte classification. Hepatology. 1981;1:673–676.
   PubMedGoogle Scholar
• Peng Y, Qi X, Guo X. Child-pugh versus meld score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine (Baltimore). 2016;95:e2877.
   PubMed Web of Science ®Google Scholar